Please assess the completion status of the following clinical trial:

Trial Title: Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 8.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of Atopic Dermatitis for at least 3 months~* Investigator's Global Assessment (IGA) Score of 2 or 3~* Eczema Area Severity Index (EASI) score of 3-21~* Body Surface Area (BSA) of 2-20%~* Peak pruritus-Numerical Rating Scale (PPNRS) of Grade 2 or more~Exclusion Criteria:~* Other forms of dermatological diseases (other than atopic dermatitis)~* Fitzpatrick skin type score greater than 5~* Clinically significant abnormal ECG, vital signs, and laboratory values~* Infection with HBV, HCV, herpes zoster or tuberculosis

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- PF-06700841 0.1% cream QD (Type: EXPERIMENTAL): PF-06700841 0.1% cream applied once daily (QD)
- PF-06700841 0.3% cream QD (Type: EXPERIMENTAL): PF-06700841 0.3% cream applied once daily (QD)
- PF-06700841 1% cream QD (Type: EXPERIMENTAL): PF-06700841 1% cream applied once daily (QD)
- PF-06700841 3% cream QD (Type: EXPERIMENTAL): PF-06700841 3% cream applied once daily (QD)
- PF-06700841 0.3% cream BID (Type: EXPERIMENTAL): PF-06700841 0.3% cream applied twice daily (BID)
- PF-06700841 1% cream BID (Type: EXPERIMENTAL): PF-06700841 1% cream applied twice daily (BID)
- Vehicle cream QD (Type: PLACEBO_COMPARATOR): Vehicle cream applied once daily (QD)
- Vehicle cream BID (Type: PLACEBO_COMPARATOR): Vehicle cream applied twice daily (BID)

Based on this trial design, predict the completion outcome and termination type (if applicable).